Abstract
A major concern of using viral gene therapy is the potential for uncontrolled vector propagation and infection that might result in serious deleterious effects. To enhance the safety, several viral vectors, including vectors based on Sindbis virus, were engineered to lose their capability to replicate and spread after transduction of target cells. Such designs, however, could dramatically reduce the therapeutic potency of the viral vectors, resulting in the need for multiple dosages to achieve treatment goals. Earlier, we showed that a replication-defective (RD) Sindbis vector achieved specific tumor targeting without any adverse effects in vivo. Here, we present a replication-competent Sindbis viral vector that has an hsvtk suicide gene incorporated into ns3, an indispensable non-structural gene for viral survival. The capability of viral propagation significantly increases tumor-specific infection and enhances growth suppression of tumor compared with the conventional RD vectors. Furthermore, in the presence of the prodrug ganciclovir, the hsvtk suicide gene serves as a safety mechanism to prevent uncontrolled vector propagation. In addition to suppressing vector propagation, toxic metabolites, generated by prodrug activation, could spread to neighboring uninfected tumor cells to further enhance tumor killing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tseng JC, Hurtado A, Yee H, Levin B, Boivin C, Benet M et al. Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 2004; 64: 6684–6692.
Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, Jimenez M et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 2004; 22: 70–77.
Tseng JC, Levin B, Hirano T, Yee H, Pampeno C, Meruelo D . In vivo antitumor activity of sindbis viral vectors. J Natl Cancer Inst 2002; 94: 1790–1802.
Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH . High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 1992; 66: 4992–5001.
Levis R, Schlesinger S, Huang HV . Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol 1990; 64: 1726–1733.
Raju R, Huang HV . Analysis of Sindbis virus promoter recognition in vivo, using novel vectors with two subgenomic mRNA promoters. J Virol 1991; 65: 2501–2510.
Hahn CS, Hahn YS, Braciale TJ, Rice CM . Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci USA 1992; 89: 2679–2683.
Pugachev KV, Mason PW, Shope RE, Frey TK . Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology 1995; 212: 587–594.
Tsuji M, Bergmann CC, Takita-Sonoda Y, Murata K, Rodrigues EG, Nussenzweig RS et al. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol 1998; 72: 6907–6910.
Pierro DJ, Myles KM, Foy BD, Beaty BJ, Olson KE . Development of an orally infectious Sindbis virus transducing system that efficiently disseminates and expresses green fluorescent protein in Aedes aegypti. Insect Mol Biol 2003; 12: 107–116.
Raju R, Subramaniam SV, Hajjou M . Genesis of Sindbis virus by in vivo recombination of nonreplicative RNA precursors. J Virol 1995; 69: 7391–7401.
Weiss BG, Schlesinger S . Recombination between Sindbis virus RNAs. J Virol 1991; 65: 4017–4025.
Frolova E, Gorchakov R, Garmashova N, Atasheva S, Vergara LA, Frolov I . Formation of nsP3-specific protein complexes during Sindbis virus replication. J Virol 2006; 80: 4122–4134.
Tseng JC, Zheng Y, Yee H, Levy DE, Meruelo D . Restricted tissue tropism and acquired resistance to Sindbis viral vector expression in the absence of innate and adaptive immunity. Gene Therapy 2007; 14: 1166–1174.
Tseng JC, Zanzonico PB, Levin B, Finn R, Larson SM, Meruelo D . Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 2006; 47: 1136–1143.
Acknowledgements
We thank Dr David E Levy for providing Balb/c stat1 knockout mice and Dr Christine Pampeno for critical reading of this manuscript and helpful discussions. US Public Health Service grants CA100687 and CA68498 from the National Cancer Institute, National Institutes of Health, and the Department of Health and Human Services supported this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tseng, JC., Daniels, G. & Meruelo, D. Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategy. Gene Ther 16, 291–296 (2009). https://doi.org/10.1038/gt.2008.153
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2008.153